|
Model Number TF-19A |
Device Problem
Torn Material (3024)
|
Patient Problems
Aortic Regurgitation (1716); Death (1802)
|
Event Date 04/24/2018 |
Event Type
Death
|
Event Description
|
On (b)(6) 2013, an aortic valve replacement (avr) was performed with a 19 mm trifecta valve.In (b)(6) 2018, the patient presented cardiac failure due to severe aortic regurgitation (ar).An echocardiogram was performed and perivalvular leakage (pvl) was diagnosed.The physician believed the best procedure for treatment was to use vascular plugs to stop the pvl.On (b)(6) 2018, the physician attempted to close the pvl with vascular plug devices, but the leakage could not be controlled.Eventually, the procedure was aborted with the trifecta valve still in the patient.It is reported the patient later expired.The physician believes "as the patient's general condition had deteriorated prior to the procedure, it most likely related to her death." an autopsy was performed and pathological analysis on the valve performed.When the valve was explanted from the patient, the right coronary cusp and left coronary cusp was noted to have been torn.According to the physician, the tear sites were likely enlarged during the deployment procedure of the vascular plugs.Information on the manufacturer of the vascular plugs were not provided.
|
|
Manufacturer Narrative
|
An event of perivalvular leakage was reported.The reported leaflet tears were confirmed.All 3 leaflets contained tears.Fibrous pannus ingrowth was observed focally on the inflow surface of leaflet 1.No inflammations or significant calcifications were found to be present.A review of the device history record showed the device met specifications prior to leaving abbott manufacturing facilities.The reported event remains unknown.
|
|
Event Description
|
On (b)(6) 2013, an aortic valve replacement (avr) was performed with a 19 mm trifecta valve.In (b)(6) 2018, the patient presented in cardiac failure due to severe aortic regurgitation (ar).An echocardiogram was performed and perivalvular leakage (pvl) was diagnosed.The physician believed the best procedure for treatment was to use vascular plugs off-label to stop the pvl.On (b)(6) 2018, the physician attempted to close the pvl with five vascular plug devices (2 of model 9-avp2-006; 2 of model 9-avp2-008 and 1 of model 9-avp2-012) however; the pvl was unable to be controlled (stopped) and the procedure was aborted.There was no impact to the pvl or the implanted tricuspid valve.Information was not provided on whether the vascular plugs were left within the patient or removed.It was reported that a later point in time, the patient expired.The physician reported that "as the patient's general condition had deteriorated prior to the procedure, it most likely related to her death." an autopsy was performed and pathological analysis on the valve performed.When the valve was explanted from the patient, the right coronary cusp and left coronary cusp was noted to have been torn.Evidence of pvl was not confirmed and it was not possible to confirm the time of the valve tears.According to the physician, the tear sites were likely enlarged during the deployment procedure of the vascular plugs.No additional information including the serial number and implant date of this valve was made available despite abbott request.Patient specific information on patient identifier and weight are not available for this complaint.
|
|
Search Alerts/Recalls
|
|
|